BBHC
AMED

Brown Brothers Harriman & Co’s Amedisys AMED Stock Holding History

Brown Brothers Harriman & Co’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-21
Closed -$2.07K – 1681
2025
Q2 		$2.07K Buy
+21
New +$1.99K ﹤0.01% 1406

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Brown Brothers Harriman & Co's AMED Position: Q3 2025 in Review

Brown Brothers Harriman & Co sold out of Amedisys (AMED) in Q3 2025, closing a stake of 21 shares — an estimated $2.07K sold.

Brown Brothers Harriman & Co first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $2.07K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Brown Brothers Harriman & Co reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 21 Amedisys shares in Q3 2025, an estimated $2.07K.
  • Brown Brothers Harriman & Co first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Amedisys position peaked at $2.07K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2025, filed 13 Nov 2025.